Foundation Seminar in Haematology

8:50am Saturday, 16 October 2021
4:50pm Saturday, 16 October 2021
Seminar

The Foundation Seminar in Haematolog​y will be delivered by a combination of a self-paced online learning package and a one-day virtual seminar.​ It is designed to provide participants with key foundational skills to manage patients with a haematological malignancy. 

Participants will gain an understanding of the governance and practicalities surrounding the provision of anti-cancer therapies and develop an understanding of basic pharmacology and common toxicities. 

The sessions will focus on lymphoma and multiple myeloma management with an emphasis on common regimens, supportive medications, cancer associated thrombosis risk and infection prophylaxis. Case study sessions will provide an opportunity for participants to check chemotherapy orders and provide recommendations for supportive care.

The self-paced learning package will be available from Friday 3 September 2021.  The live virtual component of this seminar will take place on Saturday 16 October 2021.  The self-paced learning package materials must be completed prior to attending the live virtual seminar.

Please note: all attendees will have 18 weeks of access to the seminar self-paced learning package and resources from your date of enrolment into this page.  Enrolment details will be sent to registered attendees when available.

Unsure if this is the right level for you? View the seminar level descriptors.

View the preliminary program

Please note: presentation recordings from the live virtual seminar will not be available.

This seminar is now sold out. Please contact events@shpa.org.au to be added to the waitlist, check the SHPA events calendar for upcoming seminars.

Registration ratesMember Non-Member
Standard rate$560$700

All registration rates include GST

  • Register in the purple box below, then click on 'cart' at the top of the page (or under your menu options) and continue through checkout.
  • Still having trouble registering? Follow our handy ‘how to’ guide
  • Click here to view our Terms and Conditions. SHPA reserve the right to cancel a seminar or make changes to the program

* You will receive a tax invoice and separate confirmation email upon completion of your registration. If you do not receive these by the next business day, you have not completed your registration and your space is not guaranteed. Please contact the secretariat by emailing events@shpa.org.au.

PDL

Contact Information

Additional Information

Seminar Leads

  • Amanda Tey: Special Medicine Team Leader, Senior Haematology Pharmacist, Monash Health, Victoria
  • Shevon Fernando: Senior Haematology Pharmacist, Alfred Health, Victoria

Presenters

  • Hayley Vasileff, Team Leader Pharmacist - Haematology and Oncology, SA Pharmacy, Women's and Children's Hospital, Adelaide, SA
  • John Coutsouvelis, Senior Clinical Pharmacist, Alfred Health, Melbourne, Vic
  • Dr Nick Murphy, Consultant Haematologist, Royal Hobart Hospital, Hobart, Tas
  • Tristan Hughes, Specialist Pharmacist: Oncology and Haematology, Royal Hobart Hospital, Hobart, Tas
  • Hadley Bortz, Senior Pharmacist - Anticoagulation Stewardship / HTH, Alfred Health, Melbourne, Vic 
  • Dr Claire Dendle, Infectious Diseases Physician; Director Infection and Immunity Service; Director of Physician Education, Monash Health, Melbourne, Vic
  • Phil Selby, Specialist Clinical Pharmacist – Haematology, Royal Adelaide Hospital, SA Pharmacy, SA Health, Adelaide, SA 

Accreditation

This activity has been accredited for 8.33 hours of Group-1 CPD, and 9.16 hours of Group-2 CPD (a total of 26.65 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan.

The accreditation number is S2021/65.

The program addresses pharmacist competency standards, including:

  • Standard 1.3.1 Comply with statute law, guidelines, codes and standards
  • Standard 3.1.2 Assess medication management practices and needs
  • Standard 3.2.1 Administer medicines
  • Standard 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber
  • Standard 3.3.2 Apply clinical review findings to improve health outcomes’

(National Competency Standards Framework for Pharmacists in Australia, 2016)